Kodiak Sciences Inc (KOD)

09:35 AM

Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD) - Yahoo Finance

09:35 AM

Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target - Investing.com

Mar 31, 2025

Mar 28, 2025

Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

Mar 28, 2025

Mar 28, 2025

Charles Schwab Investment Management Inc. Sells 6,758 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Mar 28, 2025

Mar 28, 2025

Kodiak Sciences Advances Retinal Therapies with Promising Pipeline - TipRanks

Mar 28, 2025

Mar 27, 2025

Kodiak Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025

Mar 27, 2025

KODIAK SCIENCES Earnings Results: $KOD Reports Quarterly Earnings - Nasdaq

Mar 27, 2025

Mar 27, 2025

Kodiak Sciences Cuts Losses by 26%, Advances Two Phase 3 Trials with $168M War Chest - Stock Titan

Mar 27, 2025

Mar 27, 2025

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance

Mar 27, 2025

Mar 26, 2025

Is Kodiak Sciences Inc. (KOD) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 26, 2025

Mar 24, 2025

Diabetic Macular Edema Pipeline 2025: Therapies Under - openPR

Mar 24, 2025

Mar 24, 2025

Kodiak Sciences Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView

Mar 24, 2025

Mar 24, 2025

Critical Contrast: Metagenomi (NASDAQ:MGX) & Kodiak Sciences (NASDAQ:KOD) - Defense World

Mar 24, 2025

Mar 21, 2025

10 Hot Biotech Stocks Under $5 - Insider Monkey

Mar 21, 2025

Mar 19, 2025

Retinal Vein Occlusion Clinical and Non-Clinical Studies, Key - openPR

Mar 19, 2025

Mar 18, 2025

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate - MSN

Mar 18, 2025

Mar 12, 2025

Diabetic Retinopathy Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 12, 2025

Mar 12, 2025

Why Palantir (PLTR) Stock Is Up Today - The Globe and Mail

Mar 12, 2025

Mar 10, 2025

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Kodiak Sciences completes enrollment in GLOW2 Phase 3 trial - TipRanks

Mar 10, 2025

Mar 10, 2025

KODKodiak Sciences Inc. Latest Stock News & Market Updates - StockTitan

Mar 10, 2025

Mar 10, 2025

CDC To Study Vaccines and Autism, Despite Much Research Showing No Link - 69News WFMZ-TV

Mar 10, 2025

Mar 10, 2025

Clinical Trial Success: Kodiak Enrolls 250+ Patients for Novel Diabetic Eye Drug - Stock Titan

Mar 10, 2025

Mar 04, 2025

Diabetic Retinopathy Pipeline 2025: Mechanism of Action, Route - openPR

Mar 04, 2025

Feb 25, 2025

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate - Yahoo Finance

Feb 25, 2025

Feb 23, 2025

Kodiak Sciences’ Anti-VEGF Could Win Nicely On Retinal Disorders (NASDAQ:KOD) - Seeking Alpha

Feb 23, 2025

Feb 20, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Sees Large Increase in Short Interest - MarketBeat

Feb 20, 2025

Feb 17, 2025

Elisa Oyj (OTCMKTS:ELMUF) Short Interest Update - Defense World

Feb 17, 2025

Feb 17, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Sees Significant Growth in Short Interest - Defense World

Feb 17, 2025

Feb 15, 2025

166,843 Shares in Kodiak Sciences Inc. (NASDAQ:KOD) Bought by Peapod Lane Capital LLC - MarketBeat

Feb 15, 2025

Feb 12, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Feb 12, 2025

Feb 08, 2025

SG Americas Securities LLC Has $209,000 Stock Holdings in Levi Strauss & Co. (NYSE:LEVI) - American Banking and Market News

Feb 08, 2025

Feb 08, 2025

SG Americas Securities LLC Has $206,000 Stake in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Feb 08, 2025

Feb 06, 2025

Diabetic Retinopathy Market on Track for Major Expansion by 2034, According to DelveInsight | Novartis, Kodiak Sciences Inc., Regenxbio, Perfuse Therapeutics, Hoffmann-La Roche, Boehringer Ingelheim - Barchart

Feb 06, 2025

Feb 06, 2025

Diabetic Retinopathy Market on Track for Major Expansion - openPR

Feb 06, 2025

Feb 04, 2025

Quarterly Dosing Breakthrough: Kodiak's New Glaucoma Treatment Targets Root Causes - StockTitan

Feb 04, 2025

Feb 04, 2025

Kodiak Sciences Inc.'s (NASDAQ:KOD) institutional investors lost 23% over the past week but have profited from longer-term gains - Simply Wall St

Feb 04, 2025

Feb 03, 2025

JPMorgan Chase & Co. Purchases 30,735 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Feb 03, 2025

Jan 30, 2025

NASA's 2 stuck astronauts take their first spacewalk together - 69News WFMZ-TV

Jan 30, 2025

Jan 28, 2025

Polaris, General Motors And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Jan 28, 2025

Jan 27, 2025

Age-related Macular Degeneration Treatment Market Size in the 7MM was ~USD 9,840 million in 2023,is further expected to grow by 2034 | DelveInsight - The Globe and Mail

Jan 27, 2025

Jan 22, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Purchased by Barclays PLC - Defense World

Jan 22, 2025

Jan 22, 2025

Gran Tierra Energy Inc. (NYSE:GTE) Shares Bought by Barclays PLC - Defense World

Jan 22, 2025

Jan 20, 2025

Short Interest in Kodiak Sciences Inc. (NASDAQ:KOD) Rises By 8.1% - Defense World

Jan 20, 2025

Jan 20, 2025

Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Kodiak Sciences (NASDAQ:KOD) - Defense World

Jan 20, 2025

Jan 19, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Update - MarketBeat

Jan 19, 2025

Jan 15, 2025

Jane Street Group LLC Has $90,000 Stock Position in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Jan 15, 2025

Jan 13, 2025

Here’s Why Kodiak Sciences Inc. (KOD) Is Skyrocketing - MSN

Jan 13, 2025

Jan 13, 2025

Why These 24 Stocks Are Skyrocketing - Insider Monkey

Jan 13, 2025

Jan 13, 2025

KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates - MSN

Jan 13, 2025